IRWD insider buying and SEC filings, explained
Ironwood Pharmaceuticals Inc. · CIK 1446847
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$21.7M
Planned sales (10b5-1)
$821K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jul 7, 2026 | Planned (10b5-1) | Ronald Silver (Pfo & Pao) sold 127,890 shares at about $4.52 ($578K), marked as a 10b5-1 plan trade. Holdings down 29% to 313,680 shares. | SEC filing Filed Jul 9, 2026 |
| Jun 16, 2026 | Planned (10b5-1) | Julie McHugh (Director) sold 21,571 shares at about $3.73 ($80K), marked as a 10b5-1 plan trade. Holdings down 8% to 250,749 shares. | SEC filing Filed Jun 17, 2026 |
| Mar 17, 2026 | Sale | Alexander J. Denner (Director) sold 6,730,800 shares indirectly at about $3.05 ($20.5M). Indirect holdings down 42% to 9,188,635 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 17, 2026 |
| Feb 23–24, 2026 | Sale | Gregory S. Martini (CFO) sold 21,944 shares between Feb 23 and Feb 24 at about $3.73 ($82K). Holdings down 12% to 160,601 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Feb 23–24, 2026 | Sale | Minardo John (Chief Legal Officer) sold 36,492 shares between Feb 23 and Feb 24 at about $3.73 ($136K). Holdings down 9% to 363,886 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Feb 23, 2026 | Sale | Michael Shetzline (SVP, CMO, Head-Res&Drug) sold 15,570 shares at about $3.81 ($59K). Holdings down 3% to 538,437 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Feb 23–24, 2026 | Sale | Tammi L Gaskins (Chief Commercial Officer) sold 21,526 shares between Feb 23 and Feb 24 at about $3.73 ($80K). Holdings down 9% to 213,738 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Feb 23–24, 2026 | Sale | Thomas A MCCOURT (CEO and Director) sold 198,283 shares between Feb 23 and Feb 24 at about $3.73 ($740K). Holdings down 12% to 1,489,002 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Feb 23–24, 2026 | Sale | Ronald Silver (Principal Accounting Officer) sold 24,173 shares between Feb 23 and Feb 24 at about $3.73 ($90K). Holdings down 9% to 252,636 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Jan 5, 2026 | Planned (10b5-1) | Ronald Silver (Principal Accounting Officer) sold 35,416 shares at $4.60 ($163K), marked as a 10b5-1 plan trade. Holdings down 11% to 276,809 shares. | SEC filing Filed Jan 7, 2026 |
| Nov 17, 2025 | Sale | Tammi L Gaskins (Chief Commercial Officer) sold 6,016 shares at $3.32 ($20K). Holdings down 2% to 235,264 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 19, 2025 |
19 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow IRWD in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.